Quoin Pharmaceuticals (QNRX) to Release Earnings on Thursday

Quoin Pharmaceuticals (NASDAQ:QNRXGet Free Report) will post its quarterly earnings results before the market opens on Thursday, May 9th.

Quoin Pharmaceuticals (NASDAQ:QNRXGet Free Report) last issued its earnings results on Wednesday, March 13th. The company reported ($2.08) EPS for the quarter, topping the consensus estimate of ($2.37) by $0.29.

Quoin Pharmaceuticals Trading Up 3.2 %

Shares of QNRX opened at $0.77 on Wednesday. The firm has a market cap of $2.84 million, a price-to-earnings ratio of -0.08 and a beta of 1.85. The stock has a 50 day moving average of $1.02 and a 200-day moving average of $3.02. Quoin Pharmaceuticals has a 52 week low of $0.60 and a 52 week high of $12.00.

Analyst Ratings Changes

Separately, Maxim Group decreased their target price on Quoin Pharmaceuticals from $15.00 to $4.00 and set a “buy” rating for the company in a research report on Friday, March 15th.

Read Our Latest Stock Analysis on QNRX

About Quoin Pharmaceuticals

(Get Free Report)

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.

Recommended Stories

Earnings History for Quoin Pharmaceuticals (NASDAQ:QNRX)

Receive News & Ratings for Quoin Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quoin Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.